Clinical Trial Update: Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of empagliflozin- or glimepiride-based combination therapy in adults with type 2 diabetes mellitus; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• Jardiance (empagliflozin)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Diabete Type 2 | Phase 4 | Status: NOT_YET_RECRUITING